Inventor · disambiguated record
Yingyin Li
Also filed as: LI YINGYIN
0 granted patents·3 pending applications·0 citations·filing 2021–2025
Files withADVENCHEN PHARMACEUTICALS LLC3
Top patents by PatentIndex Score
3 records- 0167US2025345321A1Catequentinib (anlotinib) in sequential combination with immunotherapy for use in the treatment of cancerADVENCHEN PHARMACEUTICALS LLC·Filed 2025·Application pending·0 cites
- 0264US2022054475A1Using catequentinib (anlotinib) combining with standard chemotherapy or immunotherapy in sequential order for the cancer treatmentADVENCHEN PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 0362US2023399313A1Biological activities of 5-(2-(4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)ethyl)-5-azaspiro[2.4]-heptan-7-ol crystalline, phosphoric acid salt and its enantiomersADVENCHEN PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yingyin Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →